Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restoring the CD226 in CD8<sup>+</sup>T cells overcomes TIGIT-refractory immunity in HER2<sup>+</sup> breast cancer.

Cell death & disease·2026
Same author

Cellulose-Based Superabsorbent Hydrogel with Recyclable Moisture Regulation for Agriculture in Arid Regions.

Journal of agricultural and food chemistry·2026
Same author

Disulfidptosis-related signatures identify SPARC<sup>+</sup>/CYR61<sup>+</sup> stromal cells mediating immunosuppression in gastric cancer.

Cellular oncology (Dordrecht, Netherlands)·2026
Same author

Class prototype rectification and multi-scale feature measurement for few-shot classification of bearing surface defects.

Scientific reports·2026
Same author

Serum cystatin C levels are independently correlated with cognitive impairment in individuals with cerebral small vessel disease.

Frontiers in neuroscience·2026
Same author

Demographic Analysis of the Sun Protective Behaviours and Skin Cancer Risk of Victorian Farmers.

The Australasian journal of dermatology·2026

Related Experiment Video

Updated: May 6, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

5.8K

Aptamers as theranostic agents: modifications, serum stability and functionalisation.

Sarah Shigdar1, Joanna Macdonald, Michael O'Connor

  • 1School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, Victoria 3217, Australia. sarah.shigdar@deakin.edu.au.

Sensors (Basel, Switzerland)
|October 25, 2013
PubMed
Summary

Aptamers, selected through Systematic Evolution of Ligands by Exponential Enrichment (SELEX), are being modified with new bases. These modifications enhance stability and enable use as diagnostic and therapeutic agents.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.1K
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.0K

Related Experiment Videos

Last Updated: May 6, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

5.8K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.1K
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.0K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Chemical Biology

Background:

  • Aptamers, generated via Systematic Evolution of Ligands by Exponential Enrichment (SELEX), have existed for over two decades.
  • SELEX procedures have undergone significant modifications since their inception.

Purpose of the Study:

  • To review the use of modified bases in aptamer development.
  • To highlight aptamers' potential as therapeutic and diagnostic agents.

Main Methods:

  • Discussion of modified bases incorporation into aptamer sequences.
  • Review of aptamer functionalization strategies.

Main Results:

  • Modified bases enhance aptamer serum stability.
  • Functionalized aptamers show promise for diagnostic applications.

Conclusions:

  • Aptamer technology continues to evolve with modified bases.
  • These advancements facilitate the development of novel therapeutic and diagnostic tools.